Page 32 - Εταιρικό Comprehenshive

30 Our team of Personal Advisers is available on +44 (0) 1892 556 276
Cancer cover for International Health Plan
Surgery
9
Surgical procedures for the treatment or diagnosis of cancer, as shown in the ‘Your
cover for certain types of treatment’ section when that treatment has been
established as being effective.
9
If you would benefit from a new or experimental surgical procedure please contact
us. We will discuss your proposed surgical procedure with you and agree the level
of benefit we will pay in writing before your treatment starts. Please note that we
will only pay up to the equivalent non-experimental surgical procedure as listed in
the schedule of procedures and fees.
Be aware:
There is no cover for complications that arise as a result of authorised
experimental and unproven surgical procedures.
Preventative
8
There is no cover for preventative treatment, for example:
• Screening undertaken as a preventative measure where there are no
symptoms of cancer. For example, if you receive genetic screening, the
result of which shows a genetic predisposition to breast cancer, you would
not be covered for the screening or a prophylactic mastectomy to prevent
the development of breast cancer in the future.
9 Vaccines to prevent the development of cancer, for example vaccinations for the
prevention of cervical cancer up to the limits shown in the benefits table.
Drug therapy
9
Drug treatment of cancer (such as chemotherapy drugs, hormone therapies and
biological therapies) where the drug has been licensed for use by the European
Medicines Agency if you are receiving treatment in Europe or the Food and Drug
Administration if you are receiving treatment anywhere else in the world, and is
used within the terms of that licence.
9
There are some drug treatments for cancer that are typically given for prolonged
periods of time. Such prolonged treatment normally falls outside benefit. However
in the case of treatment of cancer we make an exception (subject to the limits
detailed below) for chemotherapy drugs and biological therapies such as
trastuzumab (Herceptin) and bevacizumab (Avastin). These drug treatments will be
covered when they are used within the terms of their licence, and up to the period
of the drug licence.
Please note: changes in drug licensing mean that cancer drug treatments covered
under this policy will change from time to time. For further information on licensed
cancer treatment please contact our team of Personal Advisers.